SCHEMBL6092865

SCHEMBL6092865

Cc1cccc(C)c1C(=O)Cc1ccc(C(=O)O)cc1-c1cccs1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.40
SRPK1 Q96SB4 1/20 0.40
RPS6KB2 Q9UBS0 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
PTGES O14684 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
MAPT P10636 2/20 0.36
ALDH1A1 P00352 2/20 0.36
GAA P10253 1/20 0.36
KEAP1 Q14145 1/20 0.36
PTPN1 P18031 1/20 0.36
MEN1 O00255 1/20 0.35
LMNA P02545 1/20 0.35
KMT2A Q03164 1/20 0.35
RARA P10276 2/20 0.35
RARB P10826 2/20 0.35
RARG P13631 1/20 0.35
TP53 P04637 1/20 0.35
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6090580 0.92 POLB (0.38) ARSRPK1RPS6KB2L3MBTL1PTGES
SCHEMBL6091614 0.87 MAPT (0.44) L3MBTL1NPC1RAB9AMAPTALDH1A1
SCHEMBL6091524 0.85 TNFRSF1A (0.44) ARSRPK1RPS6KB2L3MBTL1MAPT
SCHEMBL8379240 0.82 SRPK1 (0.47) ARSRPK1RPS6KB2PTGESNPC1
SCHEMBL6093104 0.81 MAPT (0.43) L3MBTL1NPC1RAB9AMAPTALDH1A1
SCHEMBL6092305 0.75 AR (0.42) ARSRPK1RPS6KB2L3MBTL1MAPT
SCHEMBL6093222 0.75 MAPT (0.48) L3MBTL1NPC1RAB9AMAPTALDH1A1
SCHEMBL27142785 0.75 SRPK1 (0.50) ARSRPK1RPS6KB2L3MBTL1NPC1
SCHEMBL6110903 0.74 TNFRSF1A (0.47) SRPK1RPS6KB2
SCHEMBL6091074 0.71 AR (0.38) ARSRPK1RPS6KB2L3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060063828-A1 1,2-Bis-(substituted-phenyl)-2-propen-1-ones and pharmaceutical compositions thereof ATHEROGENICS, INC. 2006-03-23 US disclosed
WO-2006004903-A2 1,2-BIS-(SUBSTITUTED-PHENYL)-2-PROPEN-1-ONES AND PHARMACEUTICAL COMPOSITIONS THEREOF ATHEROGENICS, INC. (US) 2006-01-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060063828-A1 1,2-Bis-(substituted-phenyl)-2-propen-1-ones and pharmaceutical compositions thereof ABCB11, CEL, CYP46A1 AR 2130/4885SRPK1 3318/4885RPS6KB2 1283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.